Document:

EX-10.2

 Exhibit 10.2 

CHANGE HEALTHCARE INC. 

2019 EMPLOYEE STOCK PURCHASE PLAN 

1.       Purpose and Term. 

(a)        The purpose of the Change Healthcare Inc. 2019 Employee Stock Purchase Plan, as it may be
amended and/or restated from time to time (the “Plan”), is to give Eligible Employees of Change Healthcare Inc., a Delaware corporation (the “Company”), and its Designated Companies an opportunity to purchase shares
of Common Stock and to promote its best interests and enhance its long-term performance. The Company intends for each Offering to qualify as an “employee stock purchase plan” under Code Section 423 (each, a
“Section 423 Offering”) and the Plan shall be construed so as to comply with the requirements of Code Section 423 with respect to Section 423 Offerings. Any provisions required to be included in the Plan
under Code Section 423 are hereby included as fully as though set forth in the Plan. Notwithstanding the foregoing, the Committee may also authorize Offerings that are not intended to comply with the requirements of Code Section 423, which
may, but are not required to, be made pursuant to any rules, procedures, or sub-plans (collectively, “Sub-Plans”) adopted by the Committee for such
purpose (each, a “Non-Section 423 Offering”). 

(b)        The effective date of the Plan shall be
                , 2019 (the “Effective Date”). The term of the Plan shall continue until terminated by the Board pursuant to
Section 13 or the date on which all of the shares of Common Stock available for issuance under the Plan have been issued. 

2.       Certain Definitions. 

Any term not expressly defined in the Plan but defined for purposes of Code Section 423 will have the same definition herein. In addition
to terms defined elsewhere in the Plan, the following terms shall have the meanings given below unless the Committee determines otherwise: 

(a)        “Affiliate” means any entity, other than a Subsidiary, that directly or
through one or more intermediaries is controlled by, or is under common control with, the Company, as determined by the Committee. 

(b)        “Applicable Law” means any applicable laws, rules and regulations (or
similar guidance), including but not limited to the General Corporation Law of the State of Delaware, the Securities Act, the Exchange Act, the Code and the listing or other rules of any applicable stock exchange, and the applicable laws of any
foreign country or jurisdiction where Purchase Rights are, or will be, granted. References to any applicable laws, rules and regulations, including references to any sections or other provisions of applicable laws, rules and regulations, also refer
to any successor or amended provisions thereto unless the Committee determines otherwise. Further, references to any section of a law shall be deemed to include any regulations or other interpretive guidance under such section, unless the Committee
determines otherwise. 
 (c)        “Board” means the Board of Directors of the
Company. 

  

 (d)        “Change in Control”
shall have the meaning given such term in the Change Healthcare Inc. 2019 Omnibus Incentive Plan or any successor plan thereto, in each case, as amended and/or restated from time to time (the “Omnibus Incentive Plan”). 

(e)        “Code” means the U.S. Internal Revenue Code of 1986, as amended. Reference
to a specific section of the Code or U.S. Treasury Regulation thereunder will include such section or regulation, any valid regulation or other official applicable guidance promulgated under such section, and any comparable provision of any future
legislation or regulation amending, supplementing or superseding such section or regulation. 

(f)        “Committee” means the Compensation Committee of the Board, which has
authority to administer the Plan pursuant to Section 3. All references to the Committee in the Plan shall include any administrator to which the Committee has delegated any part of its responsibilities and powers pursuant
to Section 3(b). 
 (g)        “Common Stock” means
shares of the common stock of the Company, par value $0.001 per share, and any successor securities. 

(h)        “Company” means Change Healthcare Inc., a Delaware corporation, and any
successor thereto. 
 (i)        “Compensation” means, unless otherwise determined
by the Committee, a Participant’s cash earnings, including base salary, wages, bonuses, commissions and other forms of incentive compensation (but excluding gifts, prizes, awards, relocation payments, severance, tips, gratuities, or similar
elements of compensation), determined as of the date of the Contribution or such other date or dates as may be determined by the Committee. The Committee may, in its discretion, on a uniform and nondiscriminatory basis, establish a different
definition of Compensation for an Offering. 
 (j)        “Contributions” means the
amount of Compensation contributed by a Participant through payroll deductions to fund the exercise of a Purchase Right; provided, however, that “Contributions” may also include other payments that the Committee may permit a
Participant to make to fund the exercise of a Purchase Right to the extent payroll deductions are not permitted by Applicable Law, as determined by the Company in its sole discretion. 

(k)        “Designated Company” means any Subsidiary or Affiliate, whether now
existing or existing in the future, that has been designated by the Committee from time to time in its sole discretion as eligible to participate in the Plan. The Committee may designate Subsidiaries or Affiliates as Designated Companies in a Non-Section 423 Offering. For purposes of a Section 423 Offering, only the Company and its Subsidiaries may be Designated Companies; provided, however, that at any given time, a Subsidiary that is
a Designated Company under a Section 423 Offering will not be a Designated Company under a Non-Section 423 Offering. 

(l)        “Eligible Employee” means any Employee of the Company or a Designated
Company except (unless otherwise determined by the Committee): 
 (i)        any
Employee who has been employed for less than 90 days; 

  
 2 

 (ii)         any Employee whose
customary employment is for less than 20 hours per week; or 
 (iii)        any
Employee whose customary employment is for not more than five months in any calendar year; 
 provided, however, that the
Committee may determine prior to any Offering Period that Employees outside the United States who are participating in a separate Offering or in separate Offerings shall be “Eligible Employees” even if they do not meet the requirements of
(ii) and (iii) above if and to the extent required by Applicable Law; provided, further, that the Committee, in its discretion, from time to time may, prior to the Offering Period for all Purchase Rights to be granted on the first
day of such Offering Period in an Offering determine (for each Section 423 Offering, on a uniform and nondiscriminatory basis or as otherwise permitted by U.S. Treasury Regulation Section 1.423-2)
that the definition of Eligible Employee will or will not include an individual if such individual: (A) has not completed at least 90 days of service since such individual’s last hire date (or such lesser period of time as may be
determined by the Committee in its discretion), (B) customarily works less than 20 hours per week (or such lesser period of time as may be determined by the Committee in its discretion), (C) customarily works less than five months per
calendar year (or such lesser period of time as may be determined by the Committee in its discretion), (D) is a highly compensated employee within the meaning of Code Section 414(q), or (E) is a highly compensated employee within the
meaning of Code Section 414(q) with compensation above a certain level or is an officer or subject to the disclosure requirements of Section 16(a) of the Exchange Act (provided that the exclusion is applied with respect to each
Section 423 Offering in an identical manner to all highly compensated employees of the Company or a Designated Company, as applicable, whose employees are participating in such Offering). 

No Employee shall be granted a Purchase Right under the Plan if, immediately after such grant, the Employee would own or hold options to
purchase stock of the Company or a Related Corporation possessing 5% or more of the total combined voting power or value of all classes of stock of such corporation, as determined in accordance with Code Section 423(b)(3). For these purposes,
the attribution rules of Code Section 424(d) shall apply in determining the stock ownership of such Employee. For purposes of a Non-Section 423 Offering, the provisions of
Section 5(i) shall apply. 
 (m)      “Employee” means an employee
of the Company or a Subsidiary or Affiliate. For the purposes herein, the existence of an employment relationship will be determined in accordance with U.S. Treasury Regulation Section 1.421-l(h). 

(n)        “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

 (o)        “Fair Market Value” means, unless the Committee determines otherwise,
on a given date (the “valuation date”) (i) if the Common Stock is listed on a national securities exchange, the closing sales price of the Common Stock reported on the primary exchange on which the Common Stock is listed and traded
on such date, or, if there are no such sales on that date, then on the last preceding date on which such sales were reported; (ii) if the Common Stock is not listed on any 

  
 3 

 
national securities exchange but is quoted in an inter-dealer quotation system on a last-sale basis, the average between the closing bid price and ask price reported on such date, or, if there is
no such sale on that date, then on the last preceding date on which a sale was reported; or (iii) if the Common Stock is not listed on a national securities exchange or quoted in an inter-dealer quotation system on a last sale basis, then Fair
Market Value shall be determined by the Committee in good faith to be the fair market value of the Common Stock. Notwithstanding any provision of the Plan to the contrary, no determination made with respect to the Fair Market Value of the Common
Stock subject to a Purchase Right shall be inconsistent with Code Section 423 in the case of a Section 423 Offering. 

(p)        “Grant Date” means the date of grant of a Purchase Right. The Grant Date
shall be the first day with respect to each Offering Period. 
 (q)        “Initial Offering
Period” means the initial Offering Period that begins and ends on the dates determined by the Committee. 

(r)        “Offering” means a grant of Purchase Rights to purchase shares of Common
Stock under the Plan. Each Offering will be a Section 423 Offering or a Non-Section 423 Offering. Unless otherwise specified by the Committee, each Offering shall be deemed a separate Offering, even if
the dates and other terms of the applicable Offering Periods of each such Offering are identical, and the provisions of the Plan will separately apply to each such Offering. With respect to Section 423 Offerings, the terms of each Offering need
not be identical; provided that the terms of the Plan and an Offering together satisfy Code Section 423 and the U.S. Treasury Regulations thereunder; provided, however, that a
Non-Section 423 Offering is not required to satisfy such regulations. 

(s)        “Offering Period” means any period, including the Initial Offering Period,
with respect to which a Purchase Right may be granted; provided that in no event shall an Offering Period be greater than 27 months. Following commencement of the Initial Offering Period, a new Offering Period shall begin. Notwithstanding the
foregoing, the Committee shall have the power to change the frequency and duration of the Offering Periods with respect to any Offering as it deems appropriate from time to time. 

(t)        “Parent” means any present or future corporation that is or which would be
a “parent corporation” of the Company as that term is defined in Code Section 424. 

(u)        “Participant” means an Eligible Employee who is a participant in the Plan.

 (v)        “Plan” means the Change Healthcare Inc. 2019 Employee Stock Purchase
Plan, as it may be amended and/or restated. 
 (w)        “Purchase Date” means the
date of exercise of a Purchase Right. The Purchase Date shall be the Purchase Period End Date with respect to each Purchase Period. 

(x)        “Purchase Period” means, unless otherwise determined by the Committee,
each six-month period during which an Offering is made to Eligible Employees pursuant to the Plan. There shall be one Purchase Period in each Offering Period, with such Purchase Periods beginning and ending on
the dates determined by the Committee or its designees in its or their discretion. 

  
 4 

 
Notwithstanding the foregoing, the first Purchase Period in the Initial Offering Period shall begin and end on the dates determined by the Committee or its designees in its or their discretion,
as applicable. Further, the Committee shall have the power to change the duration of Purchase Periods (including the Purchase Period Start Date and the Purchase Period End Date for any Purchase Period) with respect to any Offering; provided
that such change is announced a reasonable period of time prior to the effective date of such change; provided, further, that in no event shall a Purchase Period be greater than 27 months. 

(y)        “Purchase Period End Date” means the last day of each Purchase Period.
Unless otherwise determined by the Committee, there shall be one Purchase Period End Date in each Offering Period. 

(z)        “Purchase Period Start Date” means the first day of each Purchase Period.
Unless otherwise determined by the Committee, there shall be one Purchase Period Start Date in each Offering Period. 

(aa)      “Purchase Price” means the price per share of Common Stock subject to a Purchase
Right, as determined in accordance with Section 6(b). 
 (bb)      “Purchase
Right” means an option granted hereunder which entitles a Participant to purchase shares of Common Stock in accordance with the terms of the Plan. 

(cc)      “Related Corporation” means a Parent or Subsidiary. 

(dd)      “Securities Act” means the U.S. Securities Act of 1933, as amended. 

(ee)      “Subsidiary” means any present or future corporation that is or would be a
“subsidiary corporation” of the Company as that term is defined in Code Section 424. 

(ff)      “Tax-Related Items” means any income tax,
social insurance, payroll tax, fringe benefit tax, payment on account or other tax-related items arising in relation to a Participant’s participation in the Plan. 

3.        Administration. 

(a)        The Plan shall be administered by the Committee, unless the Board elects to assume
administration of the Plan in whole or in part. References to the “Committee” include the Board if it is acting in an administrative capacity with respect to the Plan. Committee members shall be intended to qualify as “independent
directors” (or terms of similar meaning) if and to the extent required under Applicable Law. However, the fact that a Committee member shall fail to qualify as an independent director shall not invalidate any Purchase Right or other action
taken by the Committee under the Plan. 
 (b)        In addition to action by meeting in accordance
with Applicable Law, any action of the Committee may be taken by a written instrument signed by all of the members of the Committee and any action so taken by written consent shall be as fully effective as if it had been taken by a majority of the
members at a meeting duly held and called. Subject to the provisions of the Plan and Applicable Law, the Committee shall have full and final authority, in its discretion, 

  
 5 

 
to take any action with respect to the Plan, including, without limitation, the following: (i) to establish, amend and rescind rules and regulations for the administration of the Plan;
(ii) to prescribe the form(s) of any agreements or other instruments used in connection with the Plan; (iii) to determine the terms and provisions of the Purchase Rights; (iv) to determine eligibility and adjudicate all disputed
claims filed under the Plan, including whether Eligible Employees shall participate in a Section 423 Offering or a Non-Section 423 Offering and which Subsidiaries and Affiliates shall be Designated
Companies participating in either a Section 423 Offering or a Non-Section 423 Offering; (v) reconcile any inconsistency in, correct any defect in, and/or supply any omission in the Plan and any
instrument or agreement relating to, or Purchase Rights granted under, the Plan; and (vi) to construe and interpret the Plan, the Purchase Rights, the rules and regulations, and the agreements or other written instruments, and to make all other
determinations necessary or advisable for the administration of the Plan, including, without limitation, the adoption of such Sub-Plans as are necessary or appropriate to permit the participation in the Plan
by Eligible Employees who are foreign nationals or employed outside the United States, as further set forth in Section 3(c) below. Every finding, decision and determination made by the Committee will, to the full extent
permitted by Applicable Law, be final and binding upon all parties. Except to the extent prohibited by the Plan or Applicable Law, and subject to such terms and conditions as may be established by the Committee, the Committee may appoint one or more
agents to assist in the administration of the Plan and may delegate any part of its responsibilities and powers to any such person or persons appointed by it. No member of the Board or Committee, as applicable, shall be liable while acting as
administrator for any action or determination made in good faith with respect to the Plan or any Purchase Right granted thereunder. 

(c)        Notwithstanding any provision to the contrary in this Plan, the Committee may adopt such Sub-Plans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws and procedures for jurisdictions outside of the United States, the terms of which Sub-Plans may take precedence over other provisions of this Plan, with the exception of Section 4, but unless otherwise superseded by the terms of such
Sub-Plan, the provisions of this Plan shall govern the operation of such Sub-Plan. To the extent inconsistent with the requirements of Code Section 423, any such Sub-Plan shall be considered part of a Non-Section 423 Offering, and Purchase Rights granted thereunder shall not be required by the terms of the Plan to comply with Code
Section 423. Without limiting the generality of the foregoing, the Committee is authorized to adopt Sub-Plans for particular non-U.S. jurisdictions that modify the
terms of the Plan to meet applicable local requirements regarding, without limitation, (i) eligibility to participate, (ii) the definition of Compensation, (iii) the dates and duration of Offering Periods or Purchase Periods or other
periods during which Participants may make Contributions towards the purchase of shares of Common Stock, (iv) the method of determining the Purchase Price and the discount from Fair Market Value at which shares of Common Stock may be purchased,
(v) any minimum or maximum amount of Contributions a Participant may make during an Offering Period or other specified period under the applicable Sub-Plan, (vi) the treatment of Purchase Rights upon
a Change in Control or a change in capitalization of the Company, (vii) the handling of payroll deductions, (viii) establishment of bank, building society or trust accounts to hold Contributions, (ix) payment of interest,
(x) conversion of local currency, (xi) obligations to pay payroll tax, (xii) determination of beneficiary designation requirements, (xiii) withholding procedures, and (xiv) handling of share issuances. 

  
 6 

 4.        Shares Subject to Plan; Limitations on
Purchases and Purchase Rights. 
 (a)        Shares Subject to Plan. The
aggregate number of shares of Common Stock available for the issuance of shares pursuant to the Plan shall be no more than 15,000,000 shares, which number shall be automatically increased on the first day of each fiscal year following the fiscal
year in which the Effective Date falls in an amount equal to the least of (x) 7,700,000 shares of Common Stock, (y) 2.5% of the total number of shares of Common Stock outstanding on the last day of the immediately preceding fiscal year
(assuming that all Units held by MCK Members (as such terms are defined in the Omnibus Incentive Plan) had been exchanged for an equal number of shares of Common Stock) and (z) a lower number of shares of Common Stock as determined by the
Board, subject to adjustment pursuant to Section 10. Shares of Common Stock distributed pursuant to the Plan shall be authorized but unissued shares, treasury shares or shares purchased on the open market or by private
purchase. For avoidance of doubt, up to the maximum number of shares of Common Stock reserved under this Section 4(a) may be used to satisfy purchases of shares of Common Stock under Section 423 Offerings and any
remaining portion of such maximum number of shares of Common Stock may be used to satisfy purchases of shares of Common Stock under Non-Section 423 Offerings. The Company hereby reserves sufficient authorized
shares of Common Stock to provide for the exercise of Purchase Rights. In the event that any Purchase Right expires unexercised or is terminated, surrendered or canceled without being exercised, in whole or in part, for any reason, the number of
shares of Common Stock subject to such Purchase Right shall again be available for issuance under the Plan and shall not reduce the aggregate number of shares of Common Stock available for the grant of Purchase Rights or issuance under the Plan.

 (b)        Limitations on Purchases and Purchase Rights. If, on a given Purchase Period
End Date, the number of shares of Common Stock with respect to which Purchase Rights are to be exercised exceeds the number of shares then available under the Plan, the Company shall make a pro rata allocation of the shares remaining available for
purchase in as uniform a manner as shall be practicable and as it shall determine to be equitable, and in no event shall the number of shares offered for purchase during any Offering Period exceed the number of shares then available under the Plan.
In addition, in connection with any Offering, the Committee may specify a maximum number of shares of Common Stock that may be purchased by any single Participant on any Purchase Date during such Offering. In connection with each Offering, the
Committee may specify a maximum aggregate number of shares of Common Stock that may be purchased by all Participants pursuant to such Offering. Further, in connection with each Offering that contains more than one Purchase Date, the Committee may
specify a maximum aggregate number of shares of Common Stock that may be purchased by all Participants on any or each Purchase Date under the Offering. If the aggregate purchase of shares of Common Stock issuable upon exercise of Purchase Rights
granted under the Offering would exceed any such maximum aggregate number, then, in the absence of any Committee action otherwise, the Company shall make a pro rata allocation of the shares available in as uniform a manner as shall be practicable
and as it shall determine to be equitable. In the event that any pro rata allocation is made pursuant to this Section 4(b), any Contributions of a Participant not applied to the purchase of shares during such Offering
Period shall be returned to such Participant (without interest, unless otherwise required by Applicable Law). Notwithstanding the foregoing, the Committee has authority, by resolution or otherwise, to modify the limitations on the number of shares
of Common Stock that may be purchased by a Participant in any particular Offering Period or any particular Purchase Period. 

  
 7 

 5.        Eligibility and Participation; Payroll
Deductions. 
 (a)        General. Purchase Rights may only be granted to
Eligible Employees. 
 (b)        Initial Eligibility. Any Eligible Employee who has
completed 90 days’ employment and is employed by the Company or a Designated Company on the date such Eligible Employee’s participation in the Plan is to become effective shall be eligible to be a Participant during any Offering Period
that begins on or after the end of such 90 day-period. An Employee who becomes an Eligible Employee on or after the Grant Date will not be eligible to participate in such Offering Period but may participate in
any subsequent Offering Period; provided that such Employee is still an Eligible Employee as of the Grant Date of such subsequent Offering Period. 

(c)        Leave of Absence. For purposes of participation in the Plan, a person on leave of
absence shall be deemed to be an Employee for the first 90 days of such leave of absence and such Employee’s employment shall be deemed to have terminated at the close of business on the 90th
day of such leave of absence unless such Employee shall have returned to regular full-time or part-time employment (as the case may be) prior to the close of business on such 90th day or unless such Employee has a right to reemployment that is guaranteed either by statute or contract (including, for avoidance of doubt, any guaranteed right to reemployment provided under any non-U.S. law, contract or policy). Termination by the Company of any Employee’s leave of absence, other than termination of such leave of absence on return to full-time or part-time employment, shall terminate
an Employee’s employment for all purposes of the Plan and shall terminate such Employee’s participation in the Plan and right to exercise any Purchase Right, unless such Employee has a right to reemployment that is guaranteed either by
statute or contract. 
 (d)        Commencement of Participation. An Eligible Employee shall
become a Participant by completing an authorization for Contributions on the form provided by the Company (and such other documents as may be required by the Committee) and delivering such forms and documents to the Company or an agent designated by
the Company on or before the date set therefor by the Committee, which date shall be prior to the Grant Date for the applicable Offering Period. Contributions for a Participant during an Offering Period shall commence on the applicable Purchase
Period Start Date when the Participant’s authorization for a Contribution becomes effective and shall continue for successive Purchase Periods during which the Participant is eligible to participate in the Plan, unless authorizations are
withdrawn or participation is terminated, as provided in Section 8. 

(e)        Amount of Contributions; Determination of Compensation. At the time a Participant
files an authorization for Contributions, a Participant shall elect to have deductions or other Contributions made from the Participant’s pay on each payday while participating in an Offering Period at a rate of not less than 1% nor more than
15% (in whole percentages only) of Compensation. Such Compensation rates shall be determined by the Committee in a nondiscriminatory manner consistent with the provisions of Code Section 423 in the case of a Section 423 Offering. 

(f)        Participant’s Account; No Interest. All Contributions made by a Participant
shall be credited to the Participant’s account under the Plan. A Participant may not make any separate cash payment into such account except when on leave of absence and then only as provided in Section 5(h) or unless
otherwise required by Applicable Law. In no event shall interest accrue on any Contributions made by a Participant, unless otherwise required by Applicable Law. 

  
 8 

 (g)        Changes in Payroll Deductions. A
Participant may withdraw, terminate or discontinue participation in the Plan as provided in Section 8, but no other change can be made during an Offering Period and, specifically, a Participant may not alter the amount of
Contributions for that Offering Period. Notwithstanding the foregoing, to the extent necessary to comply with the limitation of Code Section 423(b)(8), or Section 2(l), Section 4 and/or
Section 12(a) of the Plan, a Participant’s Contribution election may be decreased to 0% at any time during an Offering Period. In such event, Contributions shall continue at the newly elected rate with respect to the
next Offering Period, unless otherwise provided under the terms of the Plan or as otherwise determined by the Committee. 

(h)        Participation During Leave of Absence. If a Participant goes on a
leave of absence, such Participant shall have the right to elect to: (i) withdraw the balance in such Participant’s account pursuant to Section 8; (ii) discontinue Contributions to the Plan but remain a
Participant in the Plan; or (iii) remain a Participant in the Plan during such leave of absence, authorizing Contributions to be made from payments by the Company or a Subsidiary or Affiliate to the Participant during such leave of absence and
undertaking to make cash payments to the Plan at the end of each payroll period to the extent that amounts payable by the Company or any Subsidiary or Affiliate to such Participant are insufficient to meet such Participant’s authorized
Contributions. 
 (i)        Special Eligibility Rules for Foreign Participants.
Notwithstanding the provisions of Section 2(l), Eligible Employees who are citizens or residents of a foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens) may be
excluded from the Plan or an Offering if (i) the grant of a Purchase Right under the Plan or Offering to a citizen or resident of the foreign jurisdiction is prohibited under Applicable Law; or (ii) compliance with the Applicable Law would
cause the Plan or Offering to violate the requirements of Code Section 423. In the case of a Non-Section 423 Offering, an Eligible Employee (or group of Eligible Employees) may be excluded from
participation in the Plan or an Offering if the Committee has determined, in its sole discretion, that participation of such Eligible Employee(s) is not advisable or practicable for any reason. Further, notwithstanding the provisions of
Section 2(l), an Employee who does not otherwise qualify as an Eligible Employee may, in the Committee’s discretion, participate in a Non-Section 423 Offering if and to the
extent required by Applicable Law. 
 6.        Grant of Purchase Rights. 

(a)        Number of Shares Subject to Purchase Right. On the Grant Date, a Participant
shall be granted a Purchase Right to purchase, on each Purchase Period End Date of the Offering Period to which such Grant Date relates, at the applicable Purchase Price, such number of shares of Common Stock as is determined by dividing
(x) the amount of the Participant’s Contributions accumulated as of the Purchase Period End Date and retained in the Participant’s account as of the Purchase Period End Date by (y) the applicable Purchase Price (as determined in
accordance with Section 6(b)); provided, however, that (i) no Participant may purchase shares of Common Stock in excess of the limitations set forth in Section 4(b) or
Section 12(a), and the number of shares subject to a Purchase Right shall be adjusted as necessary to conform to such limitations; and (ii) in no event shall the aggregate number of shares deemed to be subject to
Purchase Rights during an 

  
 9 

 
Offering Period exceed the number of shares then available under the Plan or the maximum number of shares that a participant may purchase for any single Offering Period and for any single
Purchase Period (in each case, as provided in Section 4), and the number of shares deemed to be subject to Purchase Rights shall be adjusted as necessary to conform to these limitations. The Fair Market Value of the shares
of Common Stock shall be determined as provided in Section 2(o) and Section 6(b), and a Participant’s Compensation shall be determined according to Section 2(i). 

(b)        Purchase Price. The Purchase Price per share of Common Stock purchased with
Contributions made during an Offering Period for a Participant shall be equal to 85% (or such greater percentage as may be determined by the Committee prior to the commencement of an Offering Period in which such Purchase Period occurs) of the
lesser of (i) the Fair Market Value per share of Common Stock on the applicable Purchase Period End Date or (ii) the Fair Market Value of a share of Common Stock on the applicable Grant Date in which the Purchase Period occurs;
provided that in no event shall the Purchase Price per share be less than the par value per share of the Common Stock; provided, further that the Committee may determine prior to a Purchase Period to calculate the Purchase Price
for such Purchase Period solely by reference to the Fair Market Value of a share of Common Stock on the applicable Purchase Period End Date or Grant Date, or based on the greater (rather than the lesser) of such values. 

7.        Exercise of Purchase Rights. 

(a)        Automatic Exercise. Unless a Participant gives written notice to the Company or an
agent designated by the Company of withdrawal at least 30 days prior to the end of the Offering Period or terminates employment as hereinafter provided, the Participant’s Purchase Rights will be deemed to have been exercised automatically on
the Purchase Period End Date applicable to such Offering Period, for the purchase of the number of shares of Common Stock that the Participant’s accumulated Contributions at that time will purchase at the applicable Purchase Price (but not in
excess of the number of shares for which Purchase Rights have been granted to the Participant pursuant to Section 4 and Section 6(a)). 

(b)        Termination of Purchase Right. A Purchase Right shall expire on the earlier of
(i) the date of termination of the Participant’s employment, except as otherwise provided in Section 5(h) (regarding leaves of absence), or as otherwise required by Applicable Law, or (ii) the end of the last
day of the applicable Purchase Period. 
 (c)        Fractional Shares; Excess Amounts.
Fractional shares will not be issued under the Plan, unless otherwise determined by the Committee. Any excess Contributions in a Participant’s account that would have been used to purchase fractional shares will be automatically re-invested in a subsequent Offering Period unless the Participant timely revokes such Participant’s authorization to re-invest such excess amounts or the Company elects
to return such Contributions to the Participant. Except as permitted by the foregoing or as otherwise determined by the Committee, any amounts that were contributed but not applied toward the purchase of shares of Common Stock shall not be carried
forward to future Offering Periods and shall be returned to Participants. 
 (d)        Share
Certificates; Credit to Participant Accounts. As promptly as practicable after the Purchase Period End Date of each Purchase Period, the shares of Common Stock purchased by 

  
 10 

 
a Participant for the Purchase Period shall be credited to such Participant’s account maintained by the Company, a stock brokerage or other financial services firm designated by the Company
or the Participant or other similar entity, unless the Participant elects to have the Company deliver to the Participant certificates for the shares of Common Stock purchased upon exercise of the Participant’s Purchase Right. If a Participant
elects to have shares credited to the Participant’s account (rather than certificates issued), a report will be made available to such Participant after the close of each Purchase Period stating the entries made to such Participant’s
account, the number of shares of Common Stock purchased and the applicable Purchase Price. 

8.        Withdrawal; Termination of Employment. 

(a)        Withdrawal. A Participant may withdraw Contributions credited to the
Participant’s account during an Offering Period at any time prior to the last day of such Offering Period by giving sufficient prior written notice to the Company or an agent designated by the Company. All of the Participant’s
Contributions credited to the Participant’s account will be paid to the Participant promptly (without interest, unless otherwise required by Applicable Law) after receipt of the Participant’s notice of withdrawal, and no further
Contributions will be made from the Participant’s Compensation during such Offering Period. The Company may, at its option, treat any attempt to borrow by a Participant on the security of such Participant’s accumulated Contributions as an
election to withdraw such Contributions. A Participant’s withdrawal from any Offering Period will not have any effect upon the Participant’s eligibility to participate in any subsequent Offering Period or in any similar plan which may
hereafter be adopted by the Company. Notwithstanding the foregoing, if a Participant withdraws during an Offering Period, Contributions shall not resume at the beginning of a succeeding Offering Period unless the Participant is eligible to
participate and the Participant delivers to the Company or an agent designated by the Company a new, completed authorization form (and such other documents as may be required by the Committee) and otherwise complies with the terms of the Plan. 

(b)        Termination of Employment; Participant Ineligibility. Upon termination of a
Participant’s employment for any reason (including but not limited to termination due to death but excluding a leave of absence for a period of less than 90 days or a leave of absence of any duration where reemployment is guaranteed by either
statute or contract), or in the event that a Participant otherwise ceases to be an Eligible Employee, the Participant’s participation in the Plan shall be terminated, unless otherwise required by Applicable Law. In the event of a
Participant’s termination of employment or in the event that a Participant otherwise ceases to be an Eligible Employee, the Contributions credited to the Participant’s account will be returned (without interest, unless otherwise required
by Applicable Law) to the Participant, or, in the case of death, to a beneficiary duly designated on a form acceptable to the Committee. Any unexercised Purchase Rights granted to a Participant during any Offering Period then in effect shall be
deemed to have expired on the date of the Participant’s termination of employment or the date the Participant otherwise ceases to be an Eligible Employee, unless terminated earlier in accordance with the terms of the Plan, and no further
Contributions will be made for the Participant’s account. 

9.       Transferability. 

No Purchase Right (or rights attendant to a Purchase Right) may be transferred, assigned, pledged or hypothecated (whether by operation of law
or otherwise), except as provided by will or 

  
 11 

 
the laws of descent and distribution, and no Purchase Right shall be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation or other
disposition of a Purchase Right, or levy of attachment or similar process upon the Purchase Right not specifically permitted in the Plan, shall be null and void and without effect. A Purchase Right may be exercised during a Participant’s
lifetime only by the Participant. 
 10.     Dilution and Other Adjustments; Change in Control.

 (a)        Adjustments; Right to Issue Additional Securities. If there is any change in
the outstanding shares of Common Stock because of a merger, Change in Control, consolidation, recapitalization or reorganization involving the Company, or if the Board declares a stock dividend, stock split distributable in shares of Common Stock or
reverse stock split, other distribution (other than ordinary or regular cash dividends) or combination or reclassification of the Common Stock, or if there is a similar change in the capital stock structure of the Company affecting the Common Stock
(excluding conversion of convertible securities by the Company and/or the exercise of warrants by their holders), then the number and type of shares of Common Stock reserved for issuance under the Plan shall be correspondingly adjusted, and the
Committee shall, subject to Applicable Law, make such adjustments to Purchase Rights (such as the number and type of shares subject to a Purchase Right and the Purchase Price of a Purchase Right) or to any provisions of this Plan as the Committee
deems equitable to prevent dilution or enlargement of Purchase Rights or as may otherwise be advisable. Nothing in the Plan, a Purchase Right or any related instrument shall limit the ability of the Company to issue additional securities of any type
or class. 
 (b)        Change in Control. In addition, without limiting the effect of
Section 10(a), in the event of a Change in Control, the Committee’s discretion shall include but shall not be limited to the authority to provide for any of, or a combination of any of, the following: (i) each
Purchase Right shall be assumed or an equivalent purchase right shall be substituted by the successor entity or parent or subsidiary of such successor entity; (ii) a date selected by the Committee on or before the date of consummation of such
Change in Control shall be treated as a Purchase Date and all outstanding Purchase Rights shall be exercised on such date; (iii) all outstanding Purchase Rights shall terminate and the accumulated Contributions will be refunded to each
Participant upon or prior to the Change in Control (without interest, unless otherwise required by Applicable Law); or (iv) outstanding Purchase Rights shall continue unchanged. 

11.     Stockholder Approval of Plan. 

The Plan is subject to the approval by the stockholders of the Company, which approval shall be obtained within 12 months before or after the
date of adoption of the Plan by the Board. Amendments to the Plan shall be subject to stockholder approval to the extent, if any, as may be required by Code Section 423 or other Applicable Law. 

12.     Limitations on Purchase Rights. 

Notwithstanding any other provisions of the Plan: 

(a)        No Employee shall be granted a Purchase Right under the Plan which permits an Employee
rights to purchase stock under all employee stock purchase plans (as defined in Code 

  
 12 

 
Section 423) of the Company and any Related Corporation to accrue at a rate which exceeds $25,000 of Fair Market Value of such stock (determined at the time of the grant of such Purchase
Right) for each calendar year in which such Purchase Right is outstanding at any time in the case of a Section 423 Offering. Any Purchase Right shall be deemed to be modified to the extent necessary to satisfy this
Section 12(a). 
 (b)        In accordance with Code Section 423, all
Employees granted Purchase Rights under the Plan who are participating in a Section 423 Offering shall have the same rights and privileges under the Plan, except that the amount of Common Stock which may be purchased by any Employee under
Purchase Rights granted pursuant to the Plan shall bear a uniform relationship to the total compensation (or the basic or regular rate of compensation) of all Employees. All rules and determinations of the Committee in the administration of the Plan
shall be uniformly and consistently applied to all persons in similar circumstances. 
 13.     Amendment and
Termination of the Plan and Purchase Rights. 
 (a)        Amendment and
Termination of Plan. The Plan may be amended, altered, suspended and/or terminated at any time by the Board; provided that approval of an amendment to the Plan by the stockholders of the Company shall be required to the extent, if any,
that stockholder approval of such amendment is required by Applicable Law. 

(b)        Amendment and Termination of Purchase Rights. The Committee may (subject to the
provisions of Code Section 423 (for Section 423 Offerings) and Section 13(a)) amend, alter, suspend and/or terminate any Purchase Right, prospectively or retroactively, but (except as otherwise expressly provided
in the Plan) such amendment, alteration, suspension or termination of a Purchase Right shall not, without the written consent of a Participant with respect to an outstanding Purchase Right, materially adversely affect the rights of the Participant
with respect to the Purchase Right. 
 (c)        Amendments to Comply with Applicable Law.
Notwithstanding Section 13(a) and Section 13(b), the following provisions shall apply: 

(i)        The Committee shall have unilateral authority, subject to the provisions of
Code Section 423 (for Section 423 Offerings), to amend the Plan and any Purchase Right (without Participant consent) to the extent necessary to comply with Applicable Law or changes to Applicable Law. 

(ii)       The Committee shall have unilateral authority to make adjustments to the terms
and conditions of Purchase Rights in recognition of unusual or nonrecurring events affecting the Company or any Related Corporation, or the financial statements of the Company or any Related Corporation, or of changes in Applicable Law, or
accounting principles, if the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan or necessary or appropriate to
comply with applicable accounting principles or Applicable Law. 

  
 13 

 14.     Designation of Beneficiary. 

The Committee, in its discretion, may authorize a Participant to designate in writing a person or persons as such Participant’s
beneficiary, which beneficiary shall, in the event of such Participant’s death, be entitled to the rights, if any, to which the Participant would otherwise be entitled. The Committee shall have discretion to approve the form or forms of such
beneficiary designations, to determine whether such beneficiary designations will be accepted, and to interpret such beneficiary designations. If a deceased Participant failed to designate a beneficiary, or if the designated beneficiary does not
survive such Participant, any rights that would have been exercisable by the Participant and any benefits distributable to such Participant shall be exercised by or distributed to the legal representative of the estate of such Participant, unless
otherwise determined by the Committee. 
 15.     Miscellaneous. 

(a)        Compliance with Applicable Law. The Company may impose such restrictions on Purchase
Rights, shares of Common Stock and any other benefits underlying Purchase Rights hereunder as it may deem advisable, including without limitation restrictions under the federal securities laws, the requirements of any stock exchange or similar
organization and any blue sky, state or foreign securities or other Applicable Law. Notwithstanding any other Plan provision to the contrary, the Company shall not be obligated to issue, deliver or transfer shares of Common Stock under the Plan or
take any other action, unless such delivery or action is in compliance with Applicable Law (including but not limited to the requirements of the Securities Act). The Company will be under no obligation to register shares of Common Stock or other
securities with the Securities and Exchange Commission or to effect compliance with the exemption, registration, qualification or listing requirements of any state securities laws, stock exchange or similar organization, and the Company will have no
liability for any inability or failure to do so. The Company may cause a restrictive legend or legends to be placed on any certificate issued pursuant to a Purchase Right hereunder in such form as may be prescribed from time to time by Applicable
Law or as may be advised by legal counsel. 
 (b)        No Obligation to Exercise Purchase
Rights. The grant of a Purchase Right shall impose no obligation upon a Participant to exercise such Purchase Right. 

(c)        Application of Funds. The proceeds received by the Company from the sale of Common
Stock pursuant to Purchase Rights will be used for general corporate purposes. 

(d)        Taxes. At any time a Participant incurs a taxable event as a result of the
Participant’s participation in the Plan, a Participant must make adequate provision for any Tax-Related Items. Participants are solely responsible and liable for the satisfaction of all Tax-Related Items, and the Company shall not have any obligation to indemnify or otherwise hold any Participant harmless from any or all of such Tax-Related Items. The Company
shall have no responsibility to take or refrain from taking any actions in order to achieve a certain tax result for a Participant or any other person. 

In their sole discretion, the Company or, as applicable, the Designated Company that employs the Participant, may, unless the Committee
determines otherwise, satisfy their obligations 

  
 14 

 
to withhold Tax-Related Items by (i) withholding from the Participant’s compensation, (ii) repurchasing a sufficient whole number of shares
of Common Stock issued following exercise having an aggregate Fair Market Value sufficient to pay the Tax-Related Items required to be withheld with respect to the shares of Common Stock,
(iii) withholding from proceeds from the sale of shares of Common Stock issued upon exercise, either through a voluntary sale or a mandatory sale arranged by the Company, or (iv) any other method deemed acceptable by the Committee. 

(e)        Right to Terminate Employment. Nothing in the Plan, a Purchase Right or any
agreement or instrument related to the Plan shall confer upon an Employee the right to continue in the employment of the Company, any Related Corporation or Affiliate or affect any right which the Company, any Related Corporation or Affiliate may
have to terminate the employment of such Employee. Except as otherwise provided in the Plan or under Applicable Law, all rights of a Participant with respect to Purchase Rights granted hereunder shall terminate upon the termination of employment of
the Participant. 
 (f)        Rights as a Stockholder. No Participant or other person shall
have any rights as a stockholder unless and until certificates for shares of Common Stock are issued to the Participant or such shares are credited to the Participant’s account on the records of the Company or a designee. 

(g)        Notices. All notices or other communications by a Participant to the Company under
or in connection with the Plan will be deemed to have been duly given when received in the form and manner specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. 

(h)        Governing Law. All questions pertaining to the validity, construction and
administration of the Plan and Purchase Rights granted hereunder shall be determined in conformity with the laws of the State of Delaware, without regard to the principles of conflicts of laws, to the extent not inconsistent with Code
Section 423 (for Section 423 Offerings) or other applicable federal laws of the United States. 

(i)        Elimination of Fractional Shares. Subject to Section 7(c),
if under any provision of the Plan which requires a computation of the number of shares of Common Stock subject to a Purchase Right, the number so computed is not a whole number of shares of Common Stock, such number of shares of Common Stock shall
be rounded down to the next whole number. 
 (j)        Severability. If any provision of the
Plan shall be held illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included. 

(k)        Gender and Number. Except where otherwise indicated by the context, words in any
gender shall include any other gender, words in the singular shall include the plural and words in the plural shall include the singular. 

(l)        Rules of Construction. Headings are given to the sections of the Plan solely as a
convenience to facilitate reference. 

  
 15 

 (m)        Successors and Assigns. The Plan
shall be binding upon the Company, its successors and assigns, and Participants, their executors, administrators and permitted transferees and beneficiaries. 

(n)        Purchase Right Documentation. The grant of any Purchase Right under the Plan shall
be evidenced by such documentation, if any, as may be determined by the Committee or its designee. Such documentation may state terms, conditions and restrictions applicable to the Purchase Right and may state such other terms, conditions and
restrictions, including but not limited to terms, conditions and restrictions applicable to shares of Common Stock or other benefits subject to a Purchase Right, as may be established by the Committee. 

(o)        Uncertificated Shares. Notwithstanding anything in the Plan to the contrary, to the
extent the Plan provides for the issuance of stock certificates to reflect the issuance of shares of Common Stock, the issuance may, in the Company’s discretion, be effected on a non-certificated basis,
to the extent not prohibited by the Company’s certificate of incorporation or bylaws or by Applicable Law. 

(p)        Compliance with Recoupment, Ownership and Other Policies or Agreements.
Notwithstanding anything in the Plan to the contrary and subject to the provisions of Code Section 423 (for Section 423 Offerings), the Committee may, at any time (during or following termination of employment or service for any reason),
determine that a Participant’s rights, payments and/or benefits with respect to a Purchase Right (including but not limited to any shares issued or issuable with respect to a Purchase Right) shall be subject to reduction, cancellation,
forfeiture or recoupment upon the occurrence of certain specified events, in addition to any other conditions applicable to a Purchase Right. Such events may include, but shall not be limited to, termination of employment for cause, violation of
policies of the Company or a Related Corporation or Affiliate, breach of non-solicitation, non-competition, confidentiality,
non-disparagement or other covenants, other conduct by the Participant that is determined by the Committee to be detrimental to the business or reputation of the Company, any Related Corporation or Affiliate,
and/or other circumstances where such reduction, cancellation, forfeiture or recoupment is required by Applicable Law. In addition, without limiting the effect of the foregoing, as a condition to the grant of a Purchase Right or receipt or retention
of shares of Common Stock, cash or any other benefit under the Plan, (i) the Committee may, at any time, require that a Participant comply with any compensation recovery (or “clawback”), stock ownership, stock retention or other
policies or guidelines adopted by the Company, a Related Corporation or Affiliate, each as in effect from time to time and to the extent applicable to the Participant, and (ii) each Participant shall be subject to such compensation recovery,
recoupment, forfeiture or other similar provisions as may apply under Applicable Law. 

(q)        Plan Controls. Unless the Committee determines otherwise, in the event of a conflict
between any term or provision contained in the Plan and an express term contained in any documentation related to the Plan, the applicable terms and provisions of the Plan will govern and prevail. 

(r)        Administrative Costs. The Company or a Related Corporation or Affiliate will pay the
expenses incurred in the administration of the Plan other than any fees or transfer, excise or similar taxes imposed on the transaction pursuant to which any shares of Common Stock are 

  
 16 

 
purchased. The Participant will pay any transaction fees, commissions or similar costs on any sale of shares of Common Stock and may also be charged the reasonable costs associated with issuing a
stock certificate or similar matters. 
 (s)        Notice of Disqualifying Disposition. Each
Participant who participates in a Section 423 Offering and is subject to taxation in the United States shall give the Company prompt written notice of any disposition or other transfer of shares of Common Stock acquired pursuant to the exercise
of a Purchase Right, if such disposition or transfer is made within two years after the Grant Date or within one year after the Purchase Date. 

(t)        Data Protection. By participating in the Plan or accepting any rights granted under
it, each Participant consents to the collection and processing of personal data relating to the Participant so that the Company and its Affiliates can fulfill their obligations and exercise their rights under the Plan and generally administer the
Plan. This data will include, but may not be limited to, data about participation in the Plan and shares offered or received, purchased, or sold under the Plan from time to time and other appropriate financial and other data about the Participant
and the Participant’s participation in the Plan. 
 (u)        No Trust or Fund Created.
Neither the Plan nor any Purchase Right shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any of its Affiliates, on the one hand, and a Participant or other Person, on the
other hand. No provision of the Plan or any Purchase Right shall require the Company, for the purpose of satisfying any obligations under the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or
otherwise to segregate any assets, nor shall the Company be obligated to maintain separate bank accounts, books, records, or other evidence of the existence of a segregated or separately maintained or administered fund for such purposes.
Participants shall have no rights under the Plan other than as unsecured general creditors of the Company, except that insofar as they may have become entitled to payment of additional compensation by performance of services, they shall have the
same rights as other service providers under general law 
 16.     Code
Section 409A; Tax Qualification. 
 Purchase Rights to
purchase shares of Common Stock granted under a Section 423 Offering are exempt from the application of Code Section 409A and Code Section 457A. In furtherance of the foregoing and notwithstanding any provision in the Plan to the
contrary, if the Committee determines that a Purchase Right may be subject to Code Section 409A or Code Section 457A or that any provision in the Plan would cause a Purchase Right under the Plan to be subject to Code Section 409A or
Code Section 457A, the Committee may amend the terms of the Plan and/or of an outstanding Purchase Right, or take such other action the Committee determines is necessary or appropriate, in each case, without the Participant’s consent, to
exempt any outstanding Purchase Right or future Purchase Right from or to allow any such Purchase Rights to comply with Code Section 409A or Code Section 457A, but only to the extent any such amendments or action by the Committee would not
violate Code Section 409A or Code Section 457A. Notwithstanding the foregoing, the Company shall not have any obligation to indemnify or otherwise protect the Participant from any obligation to pay any taxes, interest or penalties pursuant
to Code Section 409A or Code Section 457A. The Company makes no representation that the Purchase Right to purchase shares of Common Stock under the Plan is compliant with Code Section 409A or Code Section 457A. 

  
 17EX-10.9

 Exhibit 10.9 

Execution Version 
 Certain identified
information has been excluded from the exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed. The excluded information is indicated by inserting the caption “[REDACTED]”
where such information is omitted. 
  
  

 
 STRATEGIC PARTNERS AGREEMENT 

by and between 
 Vista Sponsor
Holdings, L.P., 
 and 
 Miguel
Galuccio, Pablo Vera Pinto, Juan Garoby and Alejandro Cherñacov 
 in their capacity as Sponsors 

and 
 Vista Oil and Gas,
S.A.B. de C.V. 
 with the participation of Vista Management International Company Limited 

Dated as of August 1, 2017 
  

 
  

 

 STRATEGIC PARTNERS AGREEMENT 

This STRATEGIC PARTNERS AGREEMENT (this “Agreement”) is entered into on August 1, 2017 by and among: 

 

	 	(A)	 Vista Sponsor Holdings, L.P. (“Riverstone Sponsor”) a limited partnership duly organized and
validly existing under the laws of Ontario, Canada; 

  

	 	(B)	 Miguel Galuccio (“MG”), Pablo Vera Pinto (“PV”), Juan Garoby
(“JG”) and Alejandro Cherñacov (“AC”), and collectively with MG, PV and JG the “Management Sponsors” and together with Riverstone Sponsor, the “Sponsors”); and

  

	 	(C)	 Vista Oil and Gas, S.A.B. de C.V. (the “Company”) a publicly traded company (sociedad
anónima bursátil de capital variable) duly organized and validly existing under the laws of Mexico. 

 with the
participation of Vista Management International Company Limited (“Management Sponsors Entity”) a limited company duly organized and validly existing under the laws of the British Virgin Islands. 

This Agreement is subject to the following Recitals and Clauses: 

RECITALS 
 I.
WHEREAS, as of the date of execution of this Agreement, the Sponsors own, collectively, 16,368,000 Series B Shares (as defined below) issued by the Company, which represent 99.2% of all Series B Shares issued by the Company as of the date
hereof, in exchange of which the Sponsors have contributed a total of USD$25,000, corresponding to the sum of USD$[REDACTED] contributed by Riverstone Sponsor and USD$[REDACTED] contributed by Management Sponsor. 

II. WHEREAS, on July 28, 2017, the shareholders of the Company adopted the resolutions attached hereto as Exhibit
“A” (the “Shareholders’ Resolutions”) in which they approved, among other things, the issuance of Series A Shares (as defined below), the issuance of the Warrants (as defined below), the Global Offering (as
defined below), and the execution of this Agreement. 
 NOW, THEREFORE, for and in consideration of the mutual covenants and agreements
contained herein, and with the intent of the parties to be legally bound, the parties hereto agree as follows: 

  
 -2- 

 CLAUSES 

ARTICLE I 
 DEFINITIONS 

SECTION 1.01. Definition of Certain Terms. The following terms shall have the respective meaning indicated below: 

“AC” shall have the meaning set forth in the preamble to this Agreement. 

“Agreement” shall mean this Strategic Partners Agreement. 

“BMV” means the Bolsa Mexicana de Valores, S.A.B. de C.V. 

“By-laws of the Company” shall mean the
by-laws (estatutos sociales) of the Company as amended from time to time. 
 “Closing
Price” has the meaning ascribed to such term in the Internal Regulation. 
 “CNBV” means the Comisión
Nacional Bancaria y de Valores. 
 “Common Representative” shall have the definition assigned to such term in the Mexican
prospectus related to the Mexican Public Offering. 
 “Company” shall have the meaning set forth in the preamble to this
Agreement. 
 “Dollars” or “USD$” means dollars, the legal currency of the United States of America. 

“Escrow Account” means the U.K.-based escrow account into which the proceeds of the Global Offering, once converted into U.S.
dollars as necessary, and certain proceeds from the private placement of the Sponsor Warrants shall be held in deposit. 
 “Forward
Purchase Agreement” means the forward purchase agreement entered into by the Company and Riverstone Vista Capital Partners, L.P., an affiliate of Riverstone Sponsor, by means of which Riverstone Vista Capital Partners, L.P. has agreed to
buy Series A Shares and Series A Warrants pursuant to the terms and conditions set forth therein. 
 “Global Offering” or
“Offering” means the Mexican Public Offering and the International Offering, together. 
 “Indeval” means
S.D. Indeval Institución para el Depósito de Valores, S.A. de C.V. 

  
 -3- 

 “Initial Business Combination” means any merger, asset acquisition, stock
purchase, share exchange, participation or interest purchase, reorganization or other similar business combination with one or more businesses of all type of commercial or civil corporation, associations, companies, trusts or any other entities,
carried out by the Company. 
 “Initial Business Combination Closing Date” means the date on which the Initial Business
Combination becomes effective, which may be the same date on which all agreements regarding such Initial Business Combination are executed or, in the event that such agreements included conditions precedent or other similar provision, the date on
which the last of such conditions has been satisfied or waived, or in which the parties agreed that such Initial Business Combination will be in force, pursuant to the terms of the relevant agreement, as announced, as the case may be, by the Company
through EMISNET 
 “Internal Regulation” means the regulation issued by the BMV duly authorized by CNBV on
September 27, 1999, through official notice number 601-I-CGN-78755/99, including its amendments or any regulation that may
replace it. 
 “International Offering” means the offering of Series A Shares and Warrants to (i) certain qualified
institutional buyers (as defined in Rule 144A) in the United States and (ii) institutional and other investors outside the United States and Mexico that are not U.S. persons (as defined in Regulation S), pursuant to exemptions from registration
under the U.S. Securities Act of 1933. 
 “JG” shall have the meaning set forth in the preamble to this Agreement. 

“Management Sponsors” shall have the meaning set forth in the preamble to this Agreement. 

“Management Sponsors Entity” shall have the meaning set forth in the preamble to this Agreement. 

“Management Sponsor Warrants Contribution” shall have the meaning set forth in Section 3.01(a)(iii) hereof. 

“Mexican Public Offering” means the public offering of Series A Shares and Warrants in Mexico to the general public. 

“MG” shall have the meaning set forth in the preamble to this Agreement. 

“Permitted Transferee” has the meaning set forth in Section 7.03 hereof. 

“PV” shall have the meaning set forth in the preamble to this Agreement. 

  
 -4- 

 “Riverstone Sponsor” shall have the meaning set forth in the preamble to
this Agreement. 
 “Riverstone Sponsor Warrants Contribution” means (a) USD$[REDACTED], plus (b) an amount
equal to (x) [REDACTED]% of the gross proceeds of the Global Offering, plus (y) [REDACTED]% of the commission payable to the Underwriters at the closing of the Global Offering pursuant to the Underwriting Agreement, minus (c) the
Management Sponsor Warrants Contribution. 
 “RNV” means the Mexican National Registry of Securities (Registro Nacional
de Valores) 
 “Securities Market Law” or “LMV” means the Ley del Mercado de Valores of Mexico, as
amended from time to time. 
 “Series A Shares” means the Series “A”, ordinary, nominative, no par value shares,
representing the variable portion of the capital stock of the Company, registered in the Mexican National Registry of Securities (Registro Nacional de Valores) RNV of CNBV and listed in the BMV. 

“Series A Warrants” means warrants to purchase one-third of a Series A Share to be
issued by the Company under the Warrant Indenture and which are offered in the Global Offering or are kept in treasury of the Company to be delivered (i) in accordance with the Forward Purchase Agreement or (ii) pursuant to the
Shareholders Resolutions. 
 “Series B Shares” means the series “B” ordinary shares, nominative, with no par
value, representing the variable portion of the capital stock of the Company, which are convertible into Series A Shares. 

“Specified Future Issuance” has the meaning set forth in Section 4.02(a) hereof. 

“Sponsor Warrants” has the meaning set forth in Section 3.01 hereof. 

“Sponsors” shall have the meaning set forth in the preamble to this Agreement. 

“Trading Day” means each day on which the Series A Shares were or could have been negotiated in the BMV. 

“Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any
option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position, any security,
(b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or
otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b). 

  
 -5- 

 “Underwriters” means Credit Suisse Securities (USA) LLC, Citigroup Global
Markets Inc, Casa de Bolsa Credit Suisse (México), S.A. de C.V., Grupo Financiero Credit Suisse (México) and Acciones y Valores Banamex, S.A. de C.V., Casa de Bolsa, integrante del Grupo Financiero Banamex, in their capacity as initial
purchasers of the International Offering and underwriters of the Mexican Public Offering, as applicable. 
 “Underwriting
Agreement” means the agreement entered into by and among Casa de Bolsa Credit Suisse (México), S.A. de C.V., Grupo Financiero Credit Suisse (México) and Acciones y Valores Banamex, S.A. de C.V., Casa de Bolsa, integrante del
Grupo Financiero Banamex, on the one side, and the Company, on the other side, setting forth the terms under which such entities will act as underwriters of the Mexican Public Offering. 

“USD$ Closing Price” means, for any Trading Day, the Dollar equivalent of the Closing Price for such Trading Day, which shall
be determined applying the fix exchange rate (tipo de cambio fix) published by Banco de México on its webpage, with effect on such Trading Day. 

“Warrant Indenture” means the warrant issuance indenture pursuant to which the Company will issue the Series A Warrants and
the Sponsor Warrants. 
 ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

SECTION 2.01. Representations and Warranties of the Company. The Company hereby represents and warrants to each of the Sponsors: 

(a) Organization and Execution. The Company is a sociedad anónima bursátil de capital variable duly organized and
validly existing under the laws of Mexico. The Company has all requisite corporate power and authority to execute and deliver this Agreement, to carry out the provisions hereof and to perform its obligations hereunder. 

(b) Representative’s Authority. The Company’s legal representative has the necessary power and authority to execute and
deliver this Agreement on its behalf, which powers and authorities have not been modified, limited or revoked in any manner. 
 SECTION
2.02. Representations and Warranties of Riverstone Sponsor. Riverstone Sponsor hereby represents and warrants to the Company and the Management Sponsors as follows: 

(a) Organization and Execution. The Riverstone Sponsor is a limited partnership duly organized and validly existing under the laws of
Ontario, Canada. The Riverstone Sponsor has all requisite corporate power and authority to execute and deliver this Agreement, to carry out the provisions hereof and to perform its obligations hereunder 

  
 -6- 

 (b) Representative’s Authority. The Riverstone Sponsor’s legal
representative has the necessary power and authority to execute and deliver this Agreement on its behalf, which powers and authorities have not been modified, limited or revoked in any manner. 

(c) Investment Representations: 

(i) The Riverstone Sponsor understands that the Sponsor Warrants are being offered to it in a private placement that does not constitute a
“public offering” within the meaning set forth in the Mexican Securities Market Law. 
 (ii) The Riverstone Sponsor is a qualified
investor (inversionista calificado) within the meaning of the Mexican Securities Market Law and the regulations in effect as of the date hereof. 

(iii) The Riverstone Sponsor has been furnished with all materials relating to the business, finances and operations of the Company and
materials relating to the offer and sale of the Sponsor Warrants, which have been requested by the Riverstone Sponsor. The Riverstone Sponsor has been afforded the opportunity to ask questions of the executive officers and directors of the Company.
The Riverstone Sponsor understands that its investment in the Series B Shares, the Sponsor Warrants and the Series A Shares related to them involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered
necessary to make an informed investment decision with respect to the acquisition of such securities. 
 (iv) The Riverstone Sponsor has such
knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an
investment in the Securities and is able to bear the economic risk of an investment in the Sponsor Warrants in the amount contemplated hereunder for an indefinite period of time. The Riverstone Sponsor has adequate means of providing for its current
financial needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Sponsor Warrants. 

SECTION 2.03. Representations and Warranties of the Management Sponsors. Each Management Sponsor hereby represents and warrants to the
Company and the Riverstone Sponsor, with respect to itself, that: 

  
 -7- 

 (a) Execution and Authority. Such Management Sponsor has the right, power and
capacity to execute this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. 
 (b)
Investment Representations: 
 (i) Such Management Sponsor understands that the Sponsor Warrants are being offered to it in a private
placement that does not constitute a “public offering” within the meaning set forth in the Mexican Securities Market Law. 
 (ii)
Such Management Sponsor is a qualified investor (inversionista calificado) within the meaning of the Mexican Securities Market Law and the regulations in effect as of the date hereof. 

(iii) Such Management Sponsor has been furnished with all materials relating to the business, finances and operations of the Company and
materials relating to the offer and sale of the Sponsor Warrants, which have been requested by such Management Sponsor. Such Management Sponsor has been afforded the opportunity to ask questions of the executive officers and directors of the
Company. Such Management Sponsor understands that its investment in the Series B Shares, the Sponsor Warrants, and the Series A Shares related to them involves a high degree of risk and it has sought such accounting, legal and tax advice as it has
considered necessary to make an informed investment decision with respect to the acquisition of such securities. 
 (iv) Such Management
Sponsor has such knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments in the securities of companies in the development stage such as the Company, is capable of evaluating the
merits and risks of an investment in the Securities and is able to bear the economic risk of an investment in the Sponsor Warrants in the amount contemplated hereunder for an indefinite period of time. Such Management Sponsor has adequate means of
providing for its current financial needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Sponsor Warrants. 

SECTION 2.04. Representations and Warranties of the Management Sponsors Entity. The Management Sponsors Entity hereby represents and
warrants to each of the Sponsors: 
 (a) Organization and Execution. The Management Sponsors Entity is a limited company duly
organized and validly existing under the laws of the British Virgin Islands. The Management Sponsor Entity has all requisite corporate power and authority to execute and deliver this Agreement, to carry out the provisions hereof and to perform its
obligations hereunder. 

  
 -8- 

 (b) Representative’s Authority. The Management Sponsor Entity’s legal
representative has the necessary power and authority to execute and deliver this Agreement on its behalf, which powers and authorities have not been modified, limited or revoked in any manner. 

ARTICLE III SPONSOR 

WARRANTS 
 SECTION 3.01
Purchase of Sponsor Warrants. (a) On or before the pricing date of the Global Offering, the Company and the Sponsors shall execute a private placement agreement (“Private Placement Agreement”) pursuant to which the
Company shall sell, and the Sponsors shall acquire, warrants to purchase one-third of a Series A Share issued by the Company under the Warrant Indenture (“Sponsor Warrants”), at the price or
prices to be determined by the parties on such Private Placement Agreement, under the following premises: 
  

	 	(i)	 [REDACTED]% of all Sponsor Warrants shall be purchased by the Riverstone Sponsor; 

 

	 	(ii)	 [REDACTED]% of all Sponsor Warrants shall be purchased by the Management Sponsors, and further allocated among
them as provided for in such; 

  

	 	(iii)	 The total consideration to be paid by the Riverstone Sponsor for the Sponsor Warrants it purchases shall be
equal to the Riverstone Sponsor Warrants Contribution, and the total consideration to be paid by the Management Sponsors for the Sponsor Warrants they purchase shall be equal to USD$[REDACTED] (the “Management Sponsor Warrants
Contribution”); and 

  

	 	(iv)	 The purchase price of all Sponsor Warrants sold to the Sponsors shall be paid by wire transfer of immediately
available funds to the Company in accordance with the Company’s wiring instructions on the same date in which Series A Shares are settled (liquidadas) in the BMV. 

(b) The transfer of title of the Sponsor Warrants sold pursuant to the Private Placement Agreement shall occur after the pricing date of the
Global Offering, on the date on which the Series A Shares are registered in the BMV in accordance with the Global Offering, or on such date as may be mutually agreed by the Sponsors and the Company (the “Closing Date”). Once the
aggregate purchase price of all Sponsor Warrants sold to all Sponsors pursuant to the Private Placement Agreement has been paid in full, the Company shall deliver to the relevant Sponsor the related Sponsor Warrants through Indeval, at the account
of an Indeval participant notified in writing by such Sponsor to the Company. 

  
 -9- 

 SECTION 3.02 Exercise of Sponsor Warrants. (a) The parties hereby agree that
each Sponsors and its Permitted Transferee shall have the right to exercise the Sponsor Warrants they own, on a cash basis or on a cashless basis, at its own discretion, regardless if the Company has declared or not that Warrants can only be
exercised on a cashless basis in accordance with Section 9(c) of the Warrant Indenture. 
 (b) If any Sponsor or its Permitted
Transferee elects to exercise its Sponsor Warrants on a cash basis, then they shall follow the mechanism set forth in Sections 13(b) and 13(c) of the Warrant Indenture. If any Sponsor or its Permitted Transferee elects to exercise its Sponsor
Warrants on a cashless basis, then they shall follow the mechanism set forth in Section 13(d) of the Warrant Indenture; provided that (i) the “Exercise Date” (as defined in the Warrant Indenture) may be any “Business
Day” (as defined in the Warrant Indenture) within the “Exercise Period” (as defined in the Warrant Indenture), and (ii) the “US$ Fair Market Price of the Underlying Shares” (as defined in the Warrant Indenture) will be
the average of the “US$ Closing Price” (as defined in the Warrant Indenture) of the Series A Shares of the last 10 Trading Days, commencing on (and including) the Business Day on which the exercise notice is delivered. 

SECTION 3.03 Early Termination of Sponsor Warrants. (a) In the event (i) the Company declares the early termination of the
exercise period of the Warrants in accordance with Section 9(b) of the Warrant Indenture, unless such early termination occurs due to the failure to complete the Initial Business Combination, in which event the Sponsor Warrants shall expire
worthless and there is no exchange, and (ii) any Sponsor Warrants expire without being exercised, then the Company shall issue and deliver to the Sponsor or its Permitted Transferee owning such Sponsor Warrants another security, document,
instrument, or contractual arrangement that is reasonably satisfactory in form and substance to such Sponsor or Permitted Transferee, that gives such Sponsor or Permitted Transferee the right to purchase
one-third of a Series A Share in the same terms and conditions as if such Sponsor Warrants have not expired. 

(b) If the Company issues and delivers to any Sponsor or its Permitted Transferee the securities, documents, instruments or contractual
arrangements set forth in Section 3.03(a) above, the Company shall also issue or keep in its treasury a number of Series A Shares for their further delivery to the Sponsor or its Permitted Transferee, free and clear of any and all preemptive
or similar rights, in the event it exercises its rights in accordance with the terms and conditions set forth in such securities, documents, instruments or contractual arrangements. 

  
 -10- 

 ARTICLE IV 

CONVERSION OF SERIES B SHARES 

SECTION 4.01. Series B Shares as a Percentage of Capital Stock after the consummation of the Global Offering. (a) Assuming
66,000,000 Series A Shares are sold in the Global Offering, the 16,500,000 Series B Shares will represent 20% of all capital stock issued by the Company immediately after the consummation of the Global Offering. 

(b) In the event less than 66,000,000 Series A Shares are sold in the Global Offering, the Sponsors shall have the obligation to deliver to the
Company, for cancellation, such number of Series B Shares as may be necessary so that the remaining Series B Shares represent 20% of all capital stock issued by the Company immediately after the consummation of the Global Offering. The Company shall
carry out all such actions as are necessary or convenient in connection with the cancellation of such Series B Shares, including but not limited to the following: (i) the preparation and registry of all entries in the relevant corporate books
and records of the Company, (ii) the preparation, execution and delivery or exchange of any stock certificates issued by the Company, and (iii) the preparation and delivery of all required notices with the relevant governmental authorities
and regulatory entities and public registries, as the case may be. 
 SECTION 4.02. Conversion Rights and Anti-Dilution Protection.
(a) After the Initial Business Combination Closing Date, the Company shall have the obligation to convert the Series B Shares into Series A Shares on a one for one basis, subject to adjustments for stock splits, share dividends,
reorganizations, recapitalizations or other similar conditions, including the issuance, sale or delivery of additional shares representing the capital stock of the Company or other related securities to fund the Initial Business Combination
(“Specified Future Issuance”); provided that there will not be any adjustment to the conversion of Series B Shares into Series A Shares in connection with the issuance, sale or delivery of Series A Shares and Series A
Warrants under the Forward Purchase Agreement (“Forward Purchase Securities”) and provided further that the holders of more than 88% of the then-outstanding Series B Shares may agree to waive such adjustment with respect to a
Specified Future Issuance. For the avoidance of doubt, to the extent such waivers in connection with a Specified Future Issuance are not granted, then all Sponsors and their Permitted Transferees would retain the right to receive their aggregate
percentage ownership so that the Series B Shares equal 20% of the sum of the total number of all Shares issued and outstanding upon completion of the offering plus all Shares issued in the Specified Future Issuance. For clarity purposes, the
conversion of Series B Shares into Series A Shares in the terms provided in Section 4.02(b) above shall not occur prior to the consummation of the Initial Business Combination. 

(b) To convert their Series B Shares into Series A Shares, the relevant Sponsor must immediately deliver the stock certificates representing
their Series B Shares to the Company, and upon reception thereof, the Company shall deliver to such Sponsor the related Series A Shares through Indeval, at the account notified in writing to Company. 

  
 -11- 

 ARTICLE V 

WAIVERS 
 SECTION 5.01
Escrow Account. (a) The Sponsors acknowledge that, in their capacity as holders of Series B Shares, they have no right, title, interest or claim of any kind in or to any monies held in the Escrow Account or any other asset of the Company
to be used to make reimbursements and payments to holders of Series A Shareholders as provided for in the Shareholders Resolutions, and hereby waive, with respect to any Series B Shares held by it, any rights it may have in connection therewith. For
the avoidance of doubt, this acknowledgement and waiver does not affect any right of the Sponsor could have in their capacity as holders of any Series A Shares. 

(b) In the event any Sponsor transfers money to the Company as advances for future capital increases before the Initial Business Combination
Closing Date and no Initial Business Combination is completed within 24 months from the date on which the Company publishes the Global Offering placement notice (aviso de colocación), then such Sponsor hereby acknowledges that, in its
capacity as grantor of such advances for future capital increases in benefit of the Company, it has no right, title, interest or claim of any kind in or to any monies held in the Escrow Account or any other asset of the Company to be used to make
reimbursements and payments to holders of Series A Shareholders as provided for in the Shareholders Resolutions, and hereby waives, with respect to any such advances for future capital increases, any rights it may have in connection therewith. For
the avoidance of doubt, this acknowledgement and waiver does not affect the right that any Sponsor will have to receive payments of such Escrow Account in their capacity as grantors of advances for future capital increases in benefit of the Company
in the event the Initial Business Combination is completed and after any holders of any Series A Shares so electing are reimbursed and repaid as provided in the Shareholders Resolutions. 

SECTION 5.02 Incorporation of other companies. (a) The Sponsors hereby acknowledge and agree that neither they, nor any of their
affiliates, will participate in the formation or incorporation of any type of special purpose acquisition vehicles that intend to acquire oil and gas companies or assets in Mexico or Latin America, until a definitive agreement in connection with the
Initial Business Combination has been reached or in the event that such Initial Business Combination fails to be completed within the required time frame.     

(b) The Sponsors have agreed not to become, and to cause any director appointed by the Sponsors to the board of the Company not to become, an
officer or director of any other special purpose acquisition vehicles until a definitive agreement in connection with the Initial Business Combination has been reached or in the event that such Initial Business Combination fails to be completed
within the required time frame. 

  
 -12- 

 ARTICLE VI 

INDEMNITY 
 SECTION 6.01
Indemnity. (a) The Sponsor Indemnitors (as defined below) agree, severally and not jointly (mancomunada pero no solidariamente) and, with respect to each Sponsor Indemnitor, in any event subject to the limitations provided in this
Section 6.01, to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating,
preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) (“Losses”) to which the Company may become subject as a result of any claim by (i) any third party for services rendered or
products sold to the Company or (ii) a prospective target business with which the Company has entered into an acquisition agreement (a “Target”); provided, however, that such indemnification of the Company by the
Sponsor Indemnitors shall apply only to the extent necessary to ensure that such claims by a third party for services rendered (other than the Company’s independent public accountants) or products sold to the Company or a Target do not reduce
the amount of funds in the Escrow Account to below (i) USD$10 per share of the Series A Shares sold in the Global Offering or (ii) such lesser amount per Series A Shares sold in the Global Offering held in the Escrow Account as of the date
on which such funds are used to make reimbursements and payments to our Series A Shareholders, as provided for in the Shareholders Resolutions, due to reductions in the value of the escrow assets, in each case net of the interest earned on such
funds held in the Escrow Account that may be released to the Company to pay income tax obligations arising after the closing of the Global Offering and to pay working capital (not to exceed USD$750,000 annually for a maximum of 24 months from the
closing of the Global Offering) and up to USD$100,000 of interest to pay dissolution expenses. As used herein, “Sponsor Indemnitor” means either Riverstone Sponsor or Management Sponsors Entity, in either case excluding any
direct or indirect affiliate, shareholder, member or partner of such Sponsor Indemnitor or any of their respective, managers, officers or directors. 

(b) Notwithstanding the foregoing, the obligations of each Sponsor Indemnitor pursuant to the foregoing Section 6.01(a) shall be
apportioned and limited as follows: (i) Riverstone Sponsor will be responsible for [REDACTED]% of the Losses arising from any particular claim, and (ii) Management Sponsors Entity will be responsible for [REDACTED]% of the Losses arising
from such particular claim. In no event will a Sponsor Indemnitor, absent its written consent, be responsible for any Losses other than those apportioned to such Sponsor Indemnitor by the preceding sentence (with respect to any Sponsor Indemnitor,
its “Allocable Losses”). 
 (c) With respect to any Sponsor Indemnitor’s Allocable Losses, such Sponsor Indemnitor has
the right in its sole discretion to: (i) defend against any claim for such Allocable Losses with counsel of its choice if, within 30 days following receipt of written notice of the claim from the Company, such Sponsor Indemnitor notifies the
Company in writing that it shall undertake such defense; and (ii) make any payment or enter into 

  
 -13- 

 a settlement or release of any such claim in its sole discretion. For the avoidance of doubt, the payment,
settlement or release of any Sponsor Indemnitor’s Allocable Losses shall have no impact on the other Sponsor Indemnitor and its Allocable Losses, such that one Sponsor Indemnitor may choose in its sole discretion to settle its Allocable Losses
while the other Sponsor Indemnitor may choose to defend against its Allocable Losses. 
 (d) Notwithstanding anything to the contrary herein,
no Sponsor Indemnitor will have any obligation to indemnify or make any payment pursuant to Section 6.01(a) above with respect to (i) any claims by a third party (including a Target) that executed a waiver of any and all rights to
seek access to the Escrow Account, regardless of whether such executed waiver is deemed to be unenforceable against such third party, and (ii) any claims under the Company’s indemnity of the Underwriters pursuant to the purchase agreement
and the underwriting agreement between the Company and the Underwriters against certain liabilities, including any liabilities under the Securities Act of 1933 and the LMV, as amended. For the avoidance of doubt, any obligation to indemnify under
this Section 6.01 will terminate upon completion of the Initial Business Combination or the liquidation of the Escrow Account in the event the Company fails to complete an Initial Business Combination in the required time frame. 

(e) The Company shall not enter into any services or transaction agreement without a clause that is substantially similar to the form attached
hereto as Exhibit “B”, unless the board of directors, with the affirmative vote of Miguel Galuccio and Ken Ryan, approves an agreement without such clause. 

SECTION 6.02 Call Option and Irrevocable Power of Attorney. On or before the date hereof the Management Sponsors and the Management
Sponsors Entity shall, and hereby agree to, execute an irrevocable call option agreement (contrato de promesa de venta) pursuant to which the Management Sponsors shall have the obligation to sell, and the Management Sponsors Entity shall have
the right to purchase, up to all Series B Shares and up to all Sponsor Warrants owned by the Management Sponsors Entity after the Global Offering (after giving effect to any adjustment made in accordance with Section 4.01(b)) in such
amount as needed to provide the Management Sponsors Entity with sufficient funds to pay for any Indemnification Payment (as defined below). The call option shall become exercisable, for a total consideration of USD$10.00 (a) upon the receipt by the
Company of a definitive non-appealable resolution issued by a competent court ruling that the Management Sponsors Entity is required to make a payment to the Company under Section 6.01 hereof
(“Indemnification Payment”), and (b) only if such Indemnification Payment is not made by the Management Entity Sponsor to the Company within the term provided by such court resolution (or 5 business days after such resolution
is notified or published, in the event no term is included therein). Within 10 business days after the execution of the irrevocable call option agreement (contrato de promesa de venta), the Management Sponsors Entity shall grant an
irrevocable power of attorney in favor of the Company so that the Company has legal authority to (i) exercise, on behalf of the Management Sponsors Entity, all of its right under such irrevocable call

  
 -14- 

 option agreement (contrato de promesa de venta) pursuant to the first sentence of this Section,
including purchasing as many Series B Shares and Sponsor Warrants as the Company determines as necessary to provide the Management Sponsors Entity with sufficient funds to pay for any Indemnification Payment, acting pursuant to the terms and
conditions set forth in the irrevocable call option agreement (contrato de promesa de venta), and (ii) sell the Series B Shares and Sponsor Warrants so acquired from the Management Sponsors, and use the proceeds thereof to make the
Indemnification Payment. 
 ARTICLE VII 

LOCK-UP PROVISIONS 

SECTION 7.01 Lock-Up for Series B Shares. Subject to Section 7.03, the Sponsors
agree that it or he shall not Transfer any Series B Shares (or Series A Shares delivered upon conversion thereof) until the earlier of (i) one year after the Initial Business Combination Closing Date or (ii) subsequent to the Initial
Business Combination, (x) if the last USD$ Closing Price equals or exceeds 12 Dollars per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 Trading Days within any 30 Trading Day
period commencing at least 150 days after the Initial Business Combination Closing Date or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in
all of the Company’s stockholders having the right to exchange their shares of Series A Shares for cash, securities or other property. 

SECTION 7.02 Lock-up of Sponsor Warrants. Subject to Section 7.03, the Riverstone
Sponsor and each Management Sponsor agrees that it or he shall not Transfer any Sponsor Warrants (or Series A Shares delivered upon exercise of such Sponsor Warrants), until 30 days after the Initial Business Combination Closing Date. 

SECTION 7.03 Transfer Provisions. (a) Notwithstanding the provisions set forth in Sections 7.01 and 7.02, Transfers
of the Series B Shares, Sponsor Warrants and Series A Shares delivered upon the exercise or conversion of the Sponsor Warrants or the Series B Shares, as applicable, and that are held by the Riverstone Sponsor, any Management Sponsor are permitted
(i) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of the Sponsors or any affiliates of the Sponsor; (ii) in the case of an individual, by gift
to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (iii) in the case of an
individual, by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an individual, pursuant to a qualified domestic relations order; (v) by private sales or transfers made in connection with the
consummation of an Initial Business Combination at prices no greater than the price at which the securities were originally purchased; (vi) in the event of the Company’s liquidation prior to the completion of an Initial Business
Combination; (vii) in case of Riverstone Sponsor, by virtue of the laws of the province of Ontario or the 

  
 -15- 

 federal laws of Canada or the terms of its limited partnership agreement upon dissolution of the Sponsor;
and (viii) in the event of the Company’s liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Series A Shares
for cash, securities or other property subsequent to the completion of the Initial Business Combination; provided, however, that in the case of clauses (i) through (v) and (vii), these permitted transferees must enter into a written agreement
agreeing to be bound by similar transfer restrictions (each a “Permitted Transferee”). 
 (b) Any transfer of Series B
Shares (or Series A Shares delivered upon conversion thereof) Sponsor Warrants in accordance with the irrevocable call option agreement (contrato de promesa de venta) described in Section 6.02 above would not be considered a
breach to the lock up provisions set forth in Sections 7.01 and 7.02 hereof. 
 ARTICLE VIII 

STRATEGIC PARTNER 
 SECTION
8.01 Strategic Partners. (a) The parties hereto acknowledge and agree that (i) the Sponsors are strategic partners of the Company for purposes of Article 367 of the Securities Market Law; and that the maximum percentage of the
capital stock of the Company they could potentially hold is 100%, and (ii) this Agreement is recognized in the By-laws of the Company. 

(b) Accordingly, to the extent the Sponsors, individually or as a group, fall within the description of insider set forth in subparagraphs I or
II of Article 363 of the Securities Market Law, the Sponsors are nevertheless authorized to buy or sell to the Company securities representing capital stock of the Company, including the acquisition and/or sales of securities provided for in this
Agreement and the Shareholders Resolutions. 
 SECTION 8.02. Disclosure to BMV. The Company hereby agrees that in the event there is
a sale or an acquisition of securities between the Company and any of the Sponsors as provided for in Section 8.01(b), the Company shall disclose it to the BMV in terms of the applicable regulation and through the means made available by
BMV. 
 ARTICLE X 

MISCELLANEOUS 
 SECTION
9.01. Notices. (a) All notices and other communications hereunder shall be in writing and shall be deemed given when mailed, delivered personally, by facsimile or email (each of which is confirmed) or sent by an overnight courier
service, to the parties at the following addresses (or at such other address for a party as shall be specified by such party by like notice): 

  
 -16- 

 if to Management Sponsors 

Attention: Santiago Pedro Balbi 

Telephone: +54 11 4021 2326|5171-2326 

Facsimile: +54 11 4021 2301|5171-2301 

E-mail: santiago.balbi@bfmyl.com 

if to Riverstone Sponsor: 

Attention: General Counsel 

Telephone: +1 212 993 0077 

Email: legal@riverstonellc.com 

if to Management Sponsors Entity 

Attention: Santiago Pedro Balbi 

Telephone: +54 11 4021 2326|5171-2326 

Facsimile: +54 11 4021 2301|5171-2301 

E-mail: santiago.balbi@bfmyl.com 

(b) The Company hereby agrees to (i) promptly provide to Riverstone Sponsor (through the individuals authorized to receive notices and
other communications as provided above, or any other person that Riverstone Sponsor subsequently identify for such purposes) with copies of all drafts of any agreements or other documents delivered by the Management Sponsors as attorneys-in-fact of the Company and in connection with any of their activities related with any Initial Business Combination, and (ii) keep Riverstone Sponsor updated
with respect to any information received from the Management Sponsors in connection with negotiations relating to the Initial Business Combination. 

SECTION 10.02. Language and Counterparts. This Agreement is executed in English language, and has been executed in multiple
counterparts, each of which shall be deemed to be an original of this Agreement. 
 SECTION 10.03. Assignment. This Agreement and the
rights and obligations hereunder shall not be assignable or transferable by any party without the prior written consent of the other Parties to this Agreement, it being understood that the foregoing shall not be read to limit any Transfer pursuant
to this Agreement. 
 SECTION 10.04. Governing Law. This Agreement shall be governed by, construed and interpreted in accordance with
the applicable laws of Mexico. The parties hereto expressly waive any right they may have, now or in the future, to demand or seek the application of a governing law other than the laws of Mexico. 

  
 -17- 

 SECTION 10.05 Jurisdiction. Each of the parties hereto irrevocably and
unconditionally submits to the exclusive jurisdiction of the courts of Mexico City for the purpose of any action or judgment relating to or arising out of this agreement or any of the transactions contemplated hereby and to the laying of venue in
such court. 
 México City, México, August 1, 2017 

[SIGNATURE PAGES FOLLOWS] 

  
 -18- 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	VISTA SPONSOR HOLDINGS, L.P.
		
	By:	 	
             

 
			
	Name:	 	Thomas Walker
	Position:	 	 Managing Director of the
 general partner,
Riverstone
 Vista Holdings GP, L.L.C.

	
	VISTA SH, L.L.C.

 
			
		
	By:	 	  

 
			
	Name:	 	Thomas Walker
	Position:	 	Managing Director

 [Signature page to Vista Strategic Partners Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	VISTA OIL & GAS, S.A.B. DE C.V.:
		
	By:	 	  

 
			
	Name:	 	Germán Gabriel Cueva López
	Position:	 	Attorney-in-fact

 [Signature page to Vista Strategic Partners Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	VISTA MANAGEMENT INTERNATIONAL
	COMPANY LIMITED
		
	By:	 	
                 

 
			
	Name:	 	Miguel Galuccio
	Title:	 	Director

 [Signature page to Vista Strategic Partners Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	MANAGEMENT TEAM MEMBER:
		
	By:	 	
                 

	Name:	 	Miguel Galuccio

 [Signature page to Vista Strategic Partners Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	MANAGEMENT TEAM MEMBER:
		
	By:	 	
                     
    

	Name:	 	Pablo Vera Pinto

 [Signature page to Vista Strategic Partners Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	MANAGEMENT TEAM MEMBER:
		
	By:	 	
                     

	Name:	 	Juan Garoby

 [Signature page to Vista Strategic Partners Agreement] 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	MANAGEMENT TEAM MEMBER:
		
	By:	 	
                 

 
			
	Name:	 	Alejandro Cherñacov

 [Signature page to Vista Strategic Partners Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]